Filing Details

Accession Number:
0001209191-20-022624
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-02 16:50:53
Reporting Period:
2020-04-01
Accepted Time:
2020-04-02 16:50:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1639225 Livongo Health Inc. LVGO Services-Computer Programming, Data Processing, Etc. (7370) 263542036
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1783108 James Pursley C/O Livongo Health, Inc.
150 West Evelyn Avenue, Suite 150
Mountain View CA 94041
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-01 24,857 $0.36 85,430 No 4 M Direct
Common Stock Disposition 2020-04-01 13,657 $26.93 71,773 No 4 S Direct
Common Stock Disposition 2020-04-01 11,200 $27.21 60,573 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-04-01 24,857 $0.00 24,857 $0.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,786 2024-06-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $27.138, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.14 to $27.39, inclusive.
  4. Shares subject to the option are fully vested and immediately exercisable.